about
Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure.Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.The obesity paradox is not observed in chronic heart failure patients with metabolic syndrome.Impact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion.HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.The Neutrophil-to-Lymphocyte Ratio Predicts All-Cause Mortality in Patients with Implantable Cardioverter Defibrillators.Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure.A novel mouse model of aortic valve stenosis induced by direct wire injury.Impact of restrictive lung disorder on cardiovascular mortality in a general population: The Yamagata (Takahata) study.Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.Left atrial appendage dysfunction in acute cerebral embolism patients with sinus rhythm: correlation with pulse wave tissue Doppler imaging.Midkine exacerbates pressure overload-induced cardiac remodeling.The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.Ruptured Right Sinus of Valsalva Aneurysm Caused by Suspected Takayasu's Arteritis.The role of macrophage transcription factor MafB in atherosclerotic plaque stability.Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage ResponseNovel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative StressSimple measurement popularizes sarcopenia evaluation in patients with heart failureSarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failurePrognostic importance of objective nutritional indexes in patients with chronic heart failureAssociation of renal tubular damage with cardio-renal anemia syndrome in patients with heart failureAssociation of plasma thioredoxin-1 with renal tubular damage and cardiac prognosis in patients with chronic heart failurePrognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillationTherapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling
P50
Q33552771-69CF2C76-91BB-402D-BB5A-BDF4B7751AE6Q33644456-18DFFF12-8466-439A-9B68-F122F43D978FQ33644456-38669389-9DAF-4A4F-8FDA-632DE092F54BQ35728712-26589DB4-9828-483D-9CAD-DD5F2E2149B5Q36326775-8F983FCF-C5DF-4498-8596-23AA6189D368Q36847157-7F485E9B-B1E4-4189-A239-3BDD21A86E81Q36877602-5C2FC553-15B7-4A24-A762-0C166B0BE2F8Q38903953-E19C97A7-4E4C-40B6-86DC-19DC0681EEE0Q39084445-878CD71A-EFB0-4B28-B446-740AD499986AQ39304011-E6C5D399-934F-4B98-BB47-0F1B30129376Q44814316-121312EE-E90F-42C1-B3DF-A359C07F52E5Q47782795-5F66EEA7-2FD4-4F68-9C2D-1B1075B1B721Q48129465-01ED2A80-684A-4112-811A-3B13A231EAFBQ48775534-E888DCBD-8FFA-406D-B3BC-02740FE60236Q48832182-1B115A61-6EF3-49C1-811E-024745D41717Q50993823-F063D845-277C-40EB-9433-288DB1D1BD89Q52982942-2FCB3B60-E127-45EA-AA6D-099D781629FDQ53094189-5A314CC8-696B-4C18-A0D3-3BFE24D981A8Q53148422-9398F957-A164-4C3E-A371-F356097B12EBQ64081801-14982E5F-B7C9-461E-9C97-B0892ECB4F5EQ64375422-CC2AE48F-7D27-4BAE-921F-6D1E76B70A0AQ85470654-7887F3F4-22B2-4F31-BDC6-6A7C0C3D1398Q86679467-D8B1BB8B-5048-4662-ACBB-BB339E738799Q87012017-6642D078-FCF0-4187-A018-3DE2AB5DCD17Q87444431-76A02AED-5197-4D7D-AB41-DD0EEE86EA98Q87568269-E160CCD8-EA8E-4CAA-8C1B-E88C38407089Q87593067-ACDBC876-FF01-43EB-8534-7D196C05DCBFQ92496170-5756E951-BF60-4463-B16C-CCD5050B67FE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Taro Narumi
@ast
Taro Narumi
@en
Taro Narumi
@es
Taro Narumi
@nl
Taro Narumi
@sl
type
label
Taro Narumi
@ast
Taro Narumi
@en
Taro Narumi
@es
Taro Narumi
@nl
Taro Narumi
@sl
prefLabel
Taro Narumi
@ast
Taro Narumi
@en
Taro Narumi
@es
Taro Narumi
@nl
Taro Narumi
@sl
P108
P106
P108
P21
P31
P496
0000-0001-6466-9457
P569
2000-01-01T00:00:00Z